Vancouver, British Columbia--(Newsfile Corp. - November 21, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, is pleased to announce it intends to settle outstanding debts totalling approximately $25,560 owed by the Company to two arms-length consultants for services performed and payable in common shares of the Company, and which will be settled through the issuance of an aggregate of 34,540 common shares ("Shares") at a deemed price of $0.74 per Share. The Company entered into consulting agreements with each consultant as originally announced June 11, 2025 and July 9, 2025 which set out the debt settlement pricing terms, and pursuant to amending agreements with each consultant, the debt settlement price per share was amended to the greater of: 1) the Company's market price on the date that is at least 5 business days prior to the closing; or 2) the Company's 5 day VWAP calculated for the five trading day period that is at least 5 business days prior to the closing; or such higher price as may be agreed to between the parties. The Shares proposed to be issued pursuant to the debt settlements will be subject to a statutory four month and one day hold period in accordance with applicable securities laws. The closing of the debt settlements will be subject to certain customary conditions precedent, including the Company's receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the "CSE").
None of the securities to be issued in connection with the debt settlements, will be registered under the United States Securities Act of 1933, as amended, and no such securities may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About FendX Technologies Inc.
FendX is a surface protection company developing innovative solutions to help reduce the spread of harmful pathogens in everyday environments. Leveraging proprietary technologies, The Company is advancing a portfolio of protective surface coatings, including REPELWRAP film, a liquid-based nano- coating technology and a specialized Foley catheter coating. The Company is focussed on building a robust intellectual property portfolio in the surface protection space and is committed to identifying and advancing new technologies and materials that enhance hygiene and safety across healthcare, consumer and commercial settings. Learn more at: https://fendxtech.com.
ON BEHALF OF THE COMPANY
"Carolyn Myers"
Carolyn Myers
Chief Executive Officer and Director
For further information, please contact:
Investor Relations
1-800-344-9868
investor@fendxtech.com
For more information, please visit https://fendxtech.com/ and the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; statements regarding the debt settlements, and closing of the debt settlements; statements regarding expanding the Company's product and IP portfolio; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. These statements are only predictions and involve known and unknown risks which may cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking statements, including: risks that the Company will not complete financings or raise sufficient funds to complete all of its planned activities; risks that the debt settlements will not receive all required regulatory approvals, including CSE approval, or will not close; risks that the Company's products may not perform as, or have the benefits, expected; risks related to research and development activities; risks that the Company's products may not be accepted and adopted by the public; the risk that the Company will not obtain necessary approvals and/or clearances as anticipated or at all; the effects of government regulation on the Company's business; risks associated with the Company's ability to obtain and protect rights to its intellectual property; risks and uncertainties associated with the Company's ability to raise additional capital; and other factors beyond the Company's control. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity or performance. Further, any forward-looking statement speaks only as of the date on which such statement is made and, except as required by applicable law, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for management to predict all of such factors and to assess in advance the impact of such factors on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement. Readers should consult all of the information set forth herein and should also refer to the risk factor disclosure outlined in the Company's filings with the British Columbia Securities Commission on SEDAR+ at www.sedarplus.ca.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275593
SOURCE: FendX Technologies Inc.
